Table of Contents

2019-2024 Global Anticoagulant Drugs Consumption Market Report

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Anticoagulant Drugs Consumption 2014-2024
  • 2.1.2 Anticoagulant Drugs Consumption CAGR by Region
• 2.2 Anticoagulant Drugs Segment by Type
  • 2.2.1 NOACs
  • 2.2.2 Heparin
  • 2.2.3 Warfarin
  • 2.2.4 Others
• 2.3 Anticoagulant Drugs Consumption by Type
  • 2.3.1 Global Anticoagulant Drugs Consumption Market Share by Type (2014-2019)
  • 2.3.2 Global Anticoagulant Drugs Revenue and Market Share by Type (2014-2019)
  • 2.3.3 Global Anticoagulant Drugs Sale Price by Type (2014-2019)
• 2.4 Anticoagulant Drugs Segment by Application
  • 2.4.1 Hospital
  • 2.4.2 Pharmacy
  • 2.4.3 Other
• 2.5 Anticoagulant Drugs Consumption by Application
  • 2.5.1 Global Anticoagulant Drugs Consumption Market Share by Application (2014-2019)
  • 2.5.2 Global Anticoagulant Drugs Value and Market Share by Application (2014-2019)
  • 2.5.3 Global Anticoagulant Drugs Sale Price by Application (2014-2019)

3 Global Anticoagulant Drugs by Players

• 3.1 Global Anticoagulant Drugs Sales Market Share by Players
  • 3.1.1 Global Anticoagulant Drugs Sales by Players (2017-2019)
  • 3.1.2 Global Anticoagulant Drugs Sales Market Share by Players (2017-2019)
• 3.2 Global Anticoagulant Drugs Revenue Market Share by Players
  • 3.2.1 Global Anticoagulant Drugs Revenue by Players (2017-2019)
  • 3.2.2 Global Anticoagulant Drugs Revenue Market Share by Players (2017-2019)
• 3.3 Global Anticoagulant Drugs Sale Price by Players
• 3.4 Global Anticoagulant Drugs Manufacturing Base Distribution, Sales Area, Product Types by Players
  • 3.4.1 Global Anticoagulant Drugs Manufacturing Base Distribution and Sales Area by Players
  • 3.4.2 Players Anticoagulant Drugs Products Offered
• 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.6 New Products and Potential Entrants
• 3.7 Mergers & Acquisitions, Expansion

4 Anticoagulant Drugs by Regions

• 4.1 Anticoagulant Drugs by Regions
  • 4.1.1 Global Anticoagulant Drugs Consumption by Regions
  • 4.1.2 Global Anticoagulant Drugs Value by Regions
• 4.2 Americas Anticoagulant Drugs Consumption Growth
• 4.3 APAC Anticoagulant Drugs Consumption Growth
• 4.4 Europe Anticoagulant Drugs Consumption Growth
• 4.5 Middle East & Africa Anticoagulant Drugs Consumption Growth

5 Americas

• 5.1 Americas Anticoagulant Drugs Consumption by Countries
  • 5.1.1 Americas Anticoagulant Drugs Consumption by Countries (2014-2019)
  • 5.1.2 Americas Anticoagulant Drugs Value by Countries (2014-2019)
• 5.2 Americas Anticoagulant Drugs Consumption by Type
• 5.3 Americas Anticoagulant Drugs Consumption by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Anticoagulant Drugs Consumption by Countries
  • 6.1.1 APAC Anticoagulant Drugs Consumption by Countries (2014-2019)
  • 6.1.2 APAC Anticoagulant Drugs Value by Countries (2014-2019)
• 6.2 APAC Anticoagulant Drugs Consumption by Type
• 6.3 APAC Anticoagulant Drugs Consumption by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Anticoagulant Drugs by Countries
  • 7.1.1 Europe Anticoagulant Drugs Consumption by Countries (2014-2019)
  • 7.1.2 Europe Anticoagulant Drugs Value by Countries (2014-2019)
• 7.2 Europe Anticoagulant Drugs Consumption by Type
• 7.3 Europe Anticoagulant Drugs Consumption by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Anticoagulant Drugs by Countries
  • 8.1.1 Middle East & Africa Anticoagulant Drugs Consumption by Countries (2014-2019)
  • 8.1.2 Middle East & Africa Anticoagulant Drugs Value by Countries (2014-2019)
• 8.2 Middle East & Africa Anticoagulant Drugs Consumption by Type
• 8.3 Middle East & Africa Anticoagulant Drugs Consumption by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Marketing, Distributors and Customer

• 10.1 Sales Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.2 Anticoagulant Drugs Distributors
• 10.3 Anticoagulant Drugs Customer

11 Global Anticoagulant Drugs Market Forecast

• 11.1 Global Anticoagulant Drugs Consumption Forecast (2019-2024)
• 11.2 Global Anticoagulant Drugs Forecast by Regions
  • 11.2.1 Global Anticoagulant Drugs Forecast by Regions (2019-2024)
  • 11.2.2 Global Anticoagulant Drugs Value Forecast by Regions (2019-2024)
  • 11.2.3 Americas Consumption Forecast
  • 11.2.4 APAC Consumption Forecast
  • 11.2.5 Europe Consumption Forecast
  • 11.2.6 Middle East & Africa Consumption Forecast
• 11.3 Americas Forecast by Countries
  • 11.3.1 United States Market Forecast
  • 11.3.2 Canada Market Forecast
  • 11.3.3 Mexico Market Forecast
  • 11.3.4 Brazil Market Forecast
• 11.4 APAC Forecast by Countries
  • 11.4.1 China Market Forecast
  • 11.4.2 Japan Market Forecast
  • 11.4.3 Korea Market Forecast
  • 11.4.4 Southeast Asia Market Forecast
  • 11.4.5 India Market Forecast
  • 11.4.6 Australia Market Forecast
• 11.5 Europe Forecast by Countries
  • 11.5.1 Germany Market Forecast
  • 11.5.2 France Market Forecast
  • 11.5.3 UK Market Forecast
  • 11.5.4 Italy Market Forecast
  • 11.5.5 Russia Market Forecast
  • 11.5.6 Spain Market Forecast
• 11.6 Middle East & Africa Forecast by Countries
  • 11.6.1 Egypt Market Forecast
  • 11.6.2 South Africa Market Forecast
  • 11.6.3 Israel Market Forecast
  • 11.6.4 Turkey Market Forecast
  • 11.6.5 GCC Countries Market Forecast
• 11.7 Global Anticoagulant Drugs Forecast by Type
• 11.8 Global Anticoagulant Drugs Forecast by Application

12 Key Players Analysis

• 12.1 Bristol-Myers Squibb
  • 12.1.1 Company Details
  • 12.1.2 Anticoagulant Drugs Product Offered
  • 12.1.3 Bristol-Myers Squibb Anticoagulant Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.1.4 Main Business Overview
  • 12.1.5 Bristol-Myers Squibb News
• 12.2 Bayer
  • 12.2.1 Company Details
  • 12.2.2 Anticoagulant Drugs Product Offered
  • 12.2.3 Bayer Anticoagulant Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.2.4 Main Business Overview
  • 12.2.5 Bayer News
• 12.3 Pfizer
  • 12.3.1 Company Details
  • 12.3.2 Anticoagulant Drugs Product Offered
  • 12.3.3 Pfizer Anticoagulant Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.3.4 Main Business Overview
  • 12.3.5 Pfizer News
• 12.4 Johnson & Johnson
  • 12.4.1 Company Details
  • 12.4.2 Anticoagulant Drugs Product Offered
  • 12.4.3 Johnson & Johnson Anticoagulant Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.4.4 Main Business Overview
  • 12.4.5 Johnson & Johnson News
• 12.5 Sanofi
  • 12.5.1 Company Details
  • 12.5.2 Anticoagulant Drugs Product Offered
  • 12.5.3 Sanofi Anticoagulant Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.5.4 Main Business Overview
  • 12.5.5 Sanofi News
• 12.6 Boehringer Ingelheim
  • 12.6.1 Company Details
  • 12.6.2 Anticoagulant Drugs Product Offered
  • 12.6.3 Boehringer Ingelheim Anticoagulant Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.6.4 Main Business Overview
  • 12.6.5 Boehringer Ingelheim News
• 12.7 Daiichi Sankyo
  • 12.7.1 Company Details
  • 12.7.2 Anticoagulant Drugs Product Offered
  • 12.7.3 Daiichi Sankyo Anticoagulant Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.7.4 Main Business Overview
  • 12.7.5 Daiichi Sankyo News

...

13 Research Findings and Conclusion

Anticoagulant drugs (also known as blood thinners) are chemical substances that prevent or reduce coagulation of blood and prolong the blood clotting time.

According to this study, over the next five years the Anticoagulant Drugs market will register a 5.0% CAGR in terms of revenue, the global market size will reach US$ 31300 million by 2024, from US$ 24600 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Anticoagulant Drugs business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Anticoagulant Drugs market by product type, application, key manufacturers and key regions and countries.

This study considers the Anticoagulant Drugs value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
NOACs
Heparin
Warfarin
Others
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Hospital
Pharmacy
Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Bristol-Myers Squibb
Bayer
Pfizer
Johnson & Johnson
Sanofi
Boehringer Ingelheim
Daiichi Sankyo
...

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Anticoagulant Drugs consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Anticoagulant Drugs market by identifying its various subsegments.
Focuses on the key global Anticoagulant Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Anticoagulant Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Anticoagulant Drugs submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.